News Sanofi outbids J&J for Actelion merger - reports Reports suggest Sanofi could pay $30 billion for Swiss biotech.
US Vericel hopes for US hit with Maci knee treatment Tissue engineering product previously flopped in EU.
News Good news for Amgen as Repatha reverses atherosclerosis Encouraging data could point to strong outcomes data, expected next year
Views & Analysis GSK and Sanofi CEOs: it's drug prices, stupid How pharma can move on from the recent controversies around pricing is one of the industry's biggest issues.
News Pfizer's hopes for cholesterol blockbuster dashed Sales of cancer drug Ibrance also fall short of expectations.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
